Inhibrx
D

INBX

88.350
USD
-4.75
(-5.10%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
12,550
الربح لكل سهم
-9
العائد الربحي
-
P/E
-10
حجم السوق
1,300,305,261
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ سنة
buy
INBXInhibrx
2025-09-22 05:39
INBX Chart
المزيد

العنوان: Inhibrx Biosciences Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.